Raising Funds To Launch A Medical Device In Hyderabad

About Business

They have a multi wave device with advance skin sensor glocometer. This non-invasive blood glucose meter eliminates the need for blood sampling, thereby eliminating pain, needle pricks, the risk of infection spread, and bio-contamination.

Clientele type

Serving B2B, B2C and also supplying it to government.
Their clients are individuals with diabetes who require frequent blood glucose monitoring, healthcare facilities such as hospitals, clinics, and medical centres, as well as healthcare professionals such as doctors, nurses, and diabetes educators. Additionally, caregivers and family members of individuals with diabetes may also be interested in this product for ease of use and improved patient comfort.

Premises

LEASED

Lease per month (in INR): 20.00 K

Security Deposit (in INR): 2.00 L

Carpet Area: 2,000 sq ft

The premise lease is renewed every year.

Asking Price Includes

1.The promoter offer to issue 15% of shares to any investor who is in a position to invest 10cr INR or equivalent 1.2 million US $ in the company.
2. Alternate offer: The investor can take the 100% equity in the company for a consideration of a one time payment of 20cr INR or 2.5 million US $and obtain the license of patent for India for the life of the patent 20 years. The global patent PCT filed will be with the Patent holders , it can be licensed for other countries other than India globally for a royalty fee. The Inventors will continue to play an active role and support the company R&D and product development till the product is launched in the market.
3. The investor can merge their company to the existing entity of the investor by paying 10cr INR to the founders or 1.2 Million US $ .Further issue shares worth 10 cr INR or 1.25 Million US$ In the investors company or the new merged entity. Where in they will issue the license to produce and sell the product in India for the life time of the Indian patent 20 years. The global rights and PCT will remain with the patent holders, global distribution rights can be negotiated on royalty basis which can be mutually discussed and agreed upon.

Reason

Raising funds to seek strategic partners and investors who would help to accelerate the development, testing, approvals and commercialization of the product.

More Details

The team of expert researchers, engineers, and healthcare professionals have designed to make the life of a diabetic patient more comfortable with no pain and multiple tests at no cost.
The team includes a CTO, 2 software development engineers, 1. hardware engineer, 2 clinical research assistant, 1 mechanical engineer,1 product development engineer and two office staff.
The team has 25 years of experience in various technologies like microscopic digital image analysis.
Major R&D focus would be on development of Non invasive Glucometer, Hemoglobin Meter, Hba1c Meter, Alternate Imaging for X-Ray Technology